Product Information
SORE THROAT 15-3.6 MG LOZENGE is a generic product labeled by Major Pharmaceuticals, priced at $0.1449 per EA under NDC 00904625549. Its NADAC has been published 662 times since Nov 28, 2013.
Strength
15; 3.6 mg/1; mg/1
Manufacturer
Major PharmaceuticalsNDC
00904625549
Classification
Generic
Dosage Form
LOZENGE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BENZOCAINE; MENTHOLApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
12/28/2012
Pharmacological Classes
Price Statistics
The NADAC for SORE THROAT 15-3.6 MG LOZENGE has been published 662 times since Nov 28, 2013, and over the history we have for it it has risen 59.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1449 per EA |
|---|---|
| All-time high | $0.1593 (Sep 11, 2024) |
| All-time low | $0.0850 (Jan 19, 2022) |
| 52-week high | $0.1575 |
| 52-week low | $0.1449 |
| Median price | $0.0982 |
| Average price | $0.1093 |
| Largest weekly change | +76.7% (Aug 23, 2023) |
| Weeks tracked | 662 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Benzocaine and Menthol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Standardized Chemical Allergen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SORE THROAT 15-3.6 MG LOZENGE?
The current National Average Drug Acquisition Cost (NADAC) for SORE THROAT 15-3.6 MG LOZENGE, manufactured by Major Pharmaceuticals, is $0.1449 per EA (NDC 00904625549), effective Sep 30, 2026.
How has the price of SORE THROAT 15-3.6 MG LOZENGE changed over time?
Over the history we have for it, the NADAC for SORE THROAT 15-3.6 MG LOZENGE has risen 59.7%. It has been tracked across 662 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for SORE THROAT 15-3.6 MG LOZENGE?
Since Nov 28, 2013, the NADAC for SORE THROAT 15-3.6 MG LOZENGE has ranged from a low of $0.0850 (Jan 19, 2022) to a high of $0.1593 (Sep 11, 2024), with a median of $0.0982 per EA.
Are there cheaper alternatives to SORE THROAT 15-3.6 MG LOZENGE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as SORE THROAT 15-3.6 MG LOZENGE in a comparable dosage form, but none are currently priced below it.
Who manufactures SORE THROAT 15-3.6 MG LOZENGE?
SORE THROAT 15-3.6 MG LOZENGE (NDC 00904625549) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.